Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations
Drug Topics
JULY 2, 2025
This schedule also helped dictate insurance coverage of those recommended vaccines.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
JULY 2, 2025
This schedule also helped dictate insurance coverage of those recommended vaccines.
Drug Topics
JULY 6, 2025
She warned that changes in vaccine recommendations could impact insurance coverage, patient access, and ultimately public health, particularly for vulnerable populations like low-income children.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
JANUARY 2, 2025
The FDA supports development of complex generic drugs, such as GLP-1s, by funding research and informing industry through guidance as part of our ongoing efforts to increase access to needed medications, Iilun Murphy, MD, director of the Office of Generic Drugs in the FDAs Center for Drug Evaluation and Research, said in a statement.
Drug Topics
JULY 15, 2025
They will have insurance coverage, and that has helped tremendously to be able to adjust insulin doses. We have seen that explode, really kind of side by side with the GLP-1 medications to the point where now anyone on insulin, any type of insulin, even just a once-a-day, long-acting insulin, typically now has access to CGM.
The Checkup by Singlecare
AUGUST 7, 2025
It’s approved by the Food and Drug Administration (FDA) for both ADHD and narcolepsy. For this reason, it can feel disruptive when insurance coverage for Adderall changes. An insurance plan’s formulary , the list of drugs the plan covers, can change with little warning. These are general dosage guidelines.
The Checkup by Singlecare
APRIL 9, 2025
That means patients insured under those plans will likely have their Ozempic prescription covered by insurance for Ozempic s FDA -approved purpose: blood sugar management for Type 2 diabetes. Ultimately, some Aetna members may get insurance coverage for Ozempic ; some may not. How much does Ozempic cost?
The Checkup by Singlecare
AUGUST 6, 2025
Though they have the same active ingredient, tirzepatide, the Food and Drug Administration (FDA) has approved them for different indications. The benefits when comparing Zepbound to Mounjaro are limited to insurance coverage and cost. Mounjaro requires the diagnosis of diabetes in order to be covered by insurance,” Dr. Ali says.
The Checkup by Singlecare
JULY 10, 2025
Although one may seem more expensive than the other, your out-of-pocket cost can depend on several factors, such as your location, choice of pharmacy, and insurance coverage. Approved uses The Food and Drug Administration (FDA) has approved both Mounjaro and Ozempic to help manage blood sugar levels in adults with Type 2 diabetes.
Pharma Marketing Network
AUGUST 6, 2025
Today, display campaigns can be personalized based on geography, prescription behavior, specialty, and even insurance coverage. Unlike retail or travel, pharmaceutical advertisers must align every campaign with FDA, HIPAA, and internal MLR (medical, legal, regulatory) review processes. Yes, when executed properly. Absolutely.
The Checkup by Singlecare
AUGUST 6, 2025
Both types of drugs are approved by the Food and Drug Administration (FDA) to treat certain conditions, like bacterial infections. Generic medications are approved by the FDA if they have the same: Active ingredient Strength Dosage form (e.g., In some cases, brand-name versions are discontinued, leaving only the generic available.
The Checkup by Singlecare
DECEMBER 10, 2024
Trulicity (dulaglutide) and Ozempic (semaglutide) are both brand-name medications approved by the Food and Drug Administration (FDA) to help treat Type 2 diabetes. However, another medication with the same active ingredient as Ozempic has been FDA approved for weight loss and is sold under the brand name Wegovy.
The Checkup by Singlecare
NOVEMBER 6, 2024
Ozempic (semaglutide) and Mounjaro (tirzepatide) are two brand-name medications approved by the Food and Drug Administration (FDA) to help treat Type 2 diabetes. However, insurance coverage and copays vary by plan. Some people might save money by switching medications if their insurance plan covers one but not the other.
The Checkup by Singlecare
JUNE 5, 2025
Insurance often does come through if the prescription is for diabetes management, not weight loss. However, insurance coverage depends on the insurance company and plan. That’s because insurance coverage varies by plan. Some Aetna enrollees receive coverage for Mounjaro. Does Aetna cover Mounjaro?
The Checkup by Singlecare
APRIL 4, 2025
Drug costs may be affected by differences in insurance plans and specific drug formularies. Bonjesta costs about $490 for people without insurance coverage for 30, 20-20 mg extended- release tablets. Is Bonjesta covered by insurance? Insurance coverage for Bonjesta varies by plan.
The Checkup by Singlecare
AUGUST 6, 2025
That said, while both cause weight loss, only Zepbound is FDA approved for weight management, while using Ozempic for weight loss is considered off-label. Some people may wonder whether it’s possible to switch from Zepbound to Ozempic for weight loss, whether due to side effects, insurance coverage, or even a new diagnosis of Type 2 diabetes.
The Checkup by Singlecare
DECEMBER 2, 2024
However, the Food and Drug Administration (FDA) has approved a generic mixture of ipratropium and albuterol —Combivent Respimat’s active ingredients—for use by COPD patients. Check your plan’s formulary for information on copays, coinsurance, and deductibles to get a better sense of what you might pay after insurance.
The Checkup by Singlecare
MAY 28, 2025
However, Adderall and its generic version (the active ingredients amphetamine and dextroamphetamine) are also FDA-approved for the treatment of narcolepsy. That means your doctor needs to provide more information to the insurance company to explain why you need this medication, she explains.
The Checkup by Singlecare
MARCH 20, 2025
Eliquis vs. aspirin: Insurance coverage and cost comparison Eliquis and aspirin are at opposite ends of the drug price spectrum. The FDA warns that Eliquis is not recommended for those with prosthetic heart valves, antiphospholipid antibody syndrome, or requiring thrombolysis or embolectomy for pulmonary embolism.
The Checkup by Singlecare
JULY 29, 2025
They share the same active ingredient, tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist , but Zepbound is FDA-approved for weight loss and obstructive sleep apnea (OSA) in adults, while Mounjaro is FDA-approved to treat Type 2 diabetes in adults.
The Checkup by Singlecare
MARCH 4, 2025
Adults and pediatric patients 12 years and older Adults 17 years and older Qsymia vs. phentermine: Conditions treated Qsymia is approved by the Food and Drug Administration (FDA) for weight loss and long-term weight management in adults and pediatric patients 12 years and older with obesity.
The Checkup by Singlecare
FEBRUARY 4, 2025
Food and Drug Administration (FDA) to manage Type 2 diabetes mellitus. Without insurance coverage, the prices of Farxiga and Jardiance can vary depending on the pharmacy and location. Farxiga and Jardiance are two brand-name oral medications approved by the U.S. Both are sodium-glucose cotransporter 2 (SGLT2) inhibitors.
The Checkup by Singlecare
DECEMBER 30, 2024
The device is being used as approved by the Food and Drug Administration (FDA). Discuss other continuous monitoring systems with your healthcare provider While CGMs are convenient for blood sugar monitoring, they can be expensive without insurance coverage. You are an insulin user or have a history of problematic hypoglycemia.
The Checkup by Singlecare
JULY 10, 2025
Gemtesa (vibegron) is a beta-3 adrenergic agonist approved by the Food and Drug Administration (FDA) to treat OAB symptoms. However, the retail price of about $689 for 30, 75 mg tablets of brand-name Gemtesa tablets can be prohibitively expensive without insurance coverage or coupons.
pharmaphorum
JUNE 12, 2025
True visibility comes from layering pharmacy locations on top of geospatial data, such as population density, income levels, transportation access, insurance coverage, and health burden. Image Maggie McCullough 12 June, 2025 pharmacy deserts Bookmark this Oncology ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bl.
The Checkup by Singlecare
JUNE 25, 2025
This oral medication is approved by the Food and Drug Administration (FDA) for glucose control (blood sugar management) in adults with Type 2 diabetes. Without insurance or other financial assistance, the average retail price for 60, 50–1,000 mg Janumet tablets is $722. However, coverage varies by insurance plan.
The Checkup by Singlecare
JANUARY 10, 2025
In fact, NP Thyroid has not been through the FDA approval process, which is likely why many health insurance plans exclude it or require additional steps for coverage. Insurance plans generally favor FDA-approved synthetic thyroid hormones because of their proven consistency and effectiveness.
Pharmacy Times
JULY 22, 2025
Mail-order pharmacies can offer cost savings depending on insurance coverage and are well suited for filling medications for chronic conditions, as they offer 90-day supplies and automatic refills. This can expand access to underserved communities and improve patient outcomes.
The Checkup by Singlecare
JULY 7, 2025
Treatment typically involves lifestyle changes, but there are also drug treatments like Wegovy ( semaglutide ), an injectable GLP-1 medication that is FDA-approved for chronic weight management due to its effectiveness in lowering blood sugar and decreasing appetite. But as Wegovy, insurance plans typically only cover it for weight loss.
The Checkup by Singlecare
APRIL 24, 2025
It is approved by the Food and Drug Administration (FDA) for treating Type 2 diabetes. Mounjaro is not generally covered for weight loss since its not FDA approved for weight loss. Zepbound and Mounjaro are virtually the same drug with similar dosages but different FDA-approved uses.
The Checkup by Singlecare
JULY 15, 2025
The Food and Drug Administration (FDA) may no longer approve the drug based on new safety evidence. An individual may no longer fit the insurance company’s criteria for the drug. These are FDA approved to treat Type 2 Diabetes, but healthcare providers may prescribe them off-label for weight loss. 46 mg capsules $78 per 30, 7.5/46
The Checkup by Singlecare
MARCH 18, 2025
Note that while there are compounded versions of tirzepatide and semaglutide , these drugs are not FDA approved. This article focuses on the five FDA-approved versions of tirzepatide and semaglutide. Tirzepatide is the active ingredient in two medications approved by the Food and Drug Administration (FDA). What is tirzepatide?
Pharmacy Times
JULY 21, 2025
The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage. REFERENCES Afridi Z, Rauf SA, Ashraf SMN, Haque MA. Health Sci Rep. 2025;8(4):e70747.
Pharmacy Times
JULY 25, 2025
Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient. Subscribe Now!
The Checkup by Singlecare
APRIL 24, 2025
Actos is a brand-name medication that is approved by the Food and Drug Administration (FDA) to manage blood glucose (sugar) levels in adults with Type 2 diabetes mellitus. Without insurance, the average retail price of Actos is $2,111 for 90, 30 mg tablets. However, the generic version, pioglitazone, may be.
The Checkup by Singlecare
MARCH 18, 2025
Cyclobenzaprine vs. baclofen: Insurance coverage and cost comparison Cyclobenzaprine and baclofen are available in both brand-name and generic forms. Generally, generic drugs like these are covered by most insurance plans and Medicare. It’s used alongside rest and physical therapy.
The Checkup by Singlecare
APRIL 15, 2025
Ozempic was initially developed to help manage Type 2 diabetes , but like Wegovy , Zepbound is FDA-approved as a weight management treatment. Many factors influence insurance coverage of Zepbound, and it can often be highly complicated as every plan is different even when plans are from the same healthcare provider.
Pharmacy Times
JULY 22, 2025
This change mirrored a January 2025 FDA safety alert and label update that urged providers to consider genetic testing, inform patients of the risks, and discuss available options. link] FDA highlights importance of DPD deficiency discussions with patients prior to capecitabine or 5-FU treatment. NHS Press Release. link] Roses AD.
The Checkup by Singlecare
JULY 29, 2025
As an FDA-approved combination inhaler , Airsupra helps relieve asthma attacks in the moment while also helping prevent worsening asthma symptoms. The good news is that there are several ways to reduce the full cost of Airsupra , including health insurance coverage , patient assistance programs , and prescription savings cards.
The Checkup by Singlecare
APRIL 17, 2025
Food and Drug Administration (FDA) for chronic weight management in adults with a starting, or baseline , body mass index ( BMI ) of 30 or more ( obesity ). The pharmacy staff will process your prescription to check for insurance coverage. It is approved by the U.S.
The Checkup by Singlecare
JULY 2, 2025
Vyvanse (lisdexamfetamine dimesylate) is a brand-name medication that increases norepinephrine and dopamine levels in the brain and is approved by the Food and Drug Administration (FDA) to treat binge eating disorder and attention-deficit hyperactivity disorder (ADHD). However, coverage varies by plan and may depend on various factors.
The Checkup by Singlecare
JULY 7, 2025
Testosterone enanthate vs. cypionate: Insurance coverage and cost comparison Some insurance plans may provide coverage for either testosterone medication when it’s considered medically necessary. Determining what qualifies as “medically necessary,” however, can get complicated.
Drug Topics
JUNE 25, 2025
Investigators find that current practices among pharmacists are not fully in alignment with American Diabetes Association (ADA) guideline recommendations for glucagon use, with frequently identified barriers including cost, patient health literacy, and insurance coverage. of patients on a short-acting insulin and 2.3%
The Checkup by Singlecare
AUGUST 6, 2025
The Food and Drug Administration (FDA) has approved Wegovy for two main indications. There are currently no FDA-approved medications specifically for prediabetes, but some healthcare providers may prescribe metformin , a diabetes drug, off-label if they believe it’s appropriate. Does insurance cover Wegovy for prediabetes?
The Checkup by Singlecare
JULY 15, 2025
Restasis is FDA-approved for use in adults and children with chronic dry eye, aged 16 and older. The FDA notes that generic versions of prescription medications work just as well as brand versions. Without insurance, cyclosporine costs $777 for a 30-day supply of 0.05% single-use vials. appeared first on The Checkup.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content